Grandview Asset Management LLC Charles River Laboratories International, Inc. Transaction History

Grandview Asset Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 21, 2021	SELL	$294.17 - $371.65 $29,417 - $37,165	-100 Closed	0 $0
Q1 2021 May 06, 2021	BUY	$249.67 - $299.48 $24,967 - $29,948	100 New	100 $24,000
Q4 2019 Jan 28, 2020	SELL	$126.05 - $152.76 $200,293 - $242,735	-1,589 Closed	0 $0
Q2 2019 Jul 18, 2019	SELL	$123.4 - $148.55 $40,105 - $48,278	-325 Reduced 16.98%	1,589 $225,000
Q1 2019 May 07, 2019	BUY	$104.82 - $146.73 $200,625 - $280,841	1,914 New	1,914 $278,000

714

51.7M

233K

236K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $9.6B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Grandview Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Grandview Asset Management LLC with notifications on news.